Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma

Abstract Purpose The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2016-07, Vol.42 (7), p.949-955
Hauptverfasser: Paillocher, N., MD, Florczak, A.S, Richard, M., MD, Classe, J.M., MD-PhD, Oger, A.S., MD, Raro, P., MD, Wernert, R., MD, Lorimier, G., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 955
container_issue 7
container_start_page 949
container_title European journal of surgical oncology
container_volume 42
creator Paillocher, N., MD
Florczak, A.S
Richard, M., MD
Classe, J.M., MD-PhD
Oger, A.S., MD
Raro, P., MD
Wernert, R., MD
Lorimier, G., MD
description Abstract Purpose The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable invasive breast cancer. Patients and methods This retrospective single-institution study included 111 patients who underwent a mastectomy with IBR after RT and/or NACT for invasive breast carcinoma at the Institut de Cancérologie de l’Ouest Paul Papin from January 1997 to January 2012. Only patients with breast reconstruction by autologous latissimus dorsi flap with (LDI) or without (ALD) implant were considered. The primary endpoints were the delay in therapeutic sequence, post-operative complication rate, surgical revision rate, time of hospitalization and the anonymous analysis of the patient satisfaction survey. Results 111 patients underwent mastectomy after RT. The median age was 48 years old and the median body mass index (BMI) was 23.6. SSM were performed in 94.5% of cases. The median interval between the end of chemotherapy (CT) and the beginning of RT was 30 days while the median interval between the end of RT and surgery was 41 days. The rate of primary complications was 66.6% including seroma secretion (reduced to 10.8% when seroma secretion was excluded). The necrosis rate was 5.4%. The average patient satisfaction score for the reconstruction was 17 out of 20. Five-year disease-free and overall survival rates were 93.2% and 98.3% respectively with a median follow-up of 31.6 months. There was only one case of local relapse diagnosed after seven years of follow-up. Conclusion This study shows that our therapeutic sequence does not appear to increase IBR morbidity and remains within the acceptable safety margins of oncological treatment. It also gives a high quality aesthetic result that helps to maintain patient self-esteem.
doi_str_mv 10.1016/j.ejso.2016.03.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1804196770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798316300385</els_id><sourcerecordid>1804196770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-db6cf5a2f854c8007855bf440db6478d23ad69181e4b1aaab0e8815a793d79ee3</originalsourceid><addsrcrecordid>eNp9ks2O0zAUhSMEYoaBF2CBvGTTYsdO4iCEVMoAlQpI02Ft3To3U4fELrbTUd-Ux8GZzrBgwco_95zja3_OspeMzhll5Ztujl1w8zzN55TPaS4eZees4PksZ0X1ODunlZCzqpb8LHsWQkcprXlVP83O8opxwYQ8z35fHqAfIRpniWvJVwgRdXTDkdyauCOrYcDGQESyGKPr3Y0bA1kneQhmSNOPzgdDPnhMPnKF2tkQ_ajv4lrX9-7W2BvyDR003XgAG8lyh4OLO_SwPxKwDbmC6YDJcH3afUsWZJNsPZJVijNxvKtu4tgcpx4ZY2QJAcO0WNkDBHPAhx6W4LWxboDn2ZMW-oAv7seL7Meny-vll9n6--fVcrGeaVHSOGu2pW4LyFtZCC0prWRRbFshaCqISjY5h6asmWQotgwAthSlZAVUNW-qGpFfZK9PuXvvfo0YohpM0Nj3YDE9lmKSClaXVUWTND9JtXcheGzV3psB_FExqiaiqlMTUTURVZSrRDSZXt3nj9vE4q_lAWESvDsJMN3yYNCroA1anbj5hFI1zvw___0_dt0bazT0P_GIoXOjt-n9FFMhV1Rtpj81fSlWckq5LPgfDWjMbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1804196770</pqid></control><display><type>article</type><title>Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Paillocher, N., MD ; Florczak, A.S ; Richard, M., MD ; Classe, J.M., MD-PhD ; Oger, A.S., MD ; Raro, P., MD ; Wernert, R., MD ; Lorimier, G., MD</creator><creatorcontrib>Paillocher, N., MD ; Florczak, A.S ; Richard, M., MD ; Classe, J.M., MD-PhD ; Oger, A.S., MD ; Raro, P., MD ; Wernert, R., MD ; Lorimier, G., MD</creatorcontrib><description>Abstract Purpose The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable invasive breast cancer. Patients and methods This retrospective single-institution study included 111 patients who underwent a mastectomy with IBR after RT and/or NACT for invasive breast carcinoma at the Institut de Cancérologie de l’Ouest Paul Papin from January 1997 to January 2012. Only patients with breast reconstruction by autologous latissimus dorsi flap with (LDI) or without (ALD) implant were considered. The primary endpoints were the delay in therapeutic sequence, post-operative complication rate, surgical revision rate, time of hospitalization and the anonymous analysis of the patient satisfaction survey. Results 111 patients underwent mastectomy after RT. The median age was 48 years old and the median body mass index (BMI) was 23.6. SSM were performed in 94.5% of cases. The median interval between the end of chemotherapy (CT) and the beginning of RT was 30 days while the median interval between the end of RT and surgery was 41 days. The rate of primary complications was 66.6% including seroma secretion (reduced to 10.8% when seroma secretion was excluded). The necrosis rate was 5.4%. The average patient satisfaction score for the reconstruction was 17 out of 20. Five-year disease-free and overall survival rates were 93.2% and 98.3% respectively with a median follow-up of 31.6 months. There was only one case of local relapse diagnosed after seven years of follow-up. Conclusion This study shows that our therapeutic sequence does not appear to increase IBR morbidity and remains within the acceptable safety margins of oncological treatment. It also gives a high quality aesthetic result that helps to maintain patient self-esteem.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2016.03.024</identifier><identifier>PMID: 27134148</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Breast Neoplasms - therapy ; Carcinoma, Ductal, Breast - pathology ; Carcinoma, Ductal, Breast - surgery ; Carcinoma, Ductal, Breast - therapy ; Chemotherapy, Adjuvant ; Complications ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Immediate breast reconstruction ; Latissimus dorsi flap ; Local recurrence ; Mammaplasty - adverse effects ; Mammaplasty - methods ; Mastectomy - adverse effects ; Middle Aged ; Neoadjuvant Therapy - methods ; Neoplasm Recurrence, Local - prevention &amp; control ; Organ Sparing Treatments ; Patient Satisfaction ; Prognosis ; Radiotherapy, Adjuvant ; Risk Factors ; Satisfaction ; Skin ; Skin-sparing mastectomy ; Superficial Back Muscles - transplantation ; Surgery ; Surgical Flaps ; Time Factors ; Transplantation, Autologous ; Treatment Outcome</subject><ispartof>European journal of surgical oncology, 2016-07, Vol.42 (7), p.949-955</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-db6cf5a2f854c8007855bf440db6478d23ad69181e4b1aaab0e8815a793d79ee3</citedby><cites>FETCH-LOGICAL-c460t-db6cf5a2f854c8007855bf440db6478d23ad69181e4b1aaab0e8815a793d79ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2016.03.024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27134148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paillocher, N., MD</creatorcontrib><creatorcontrib>Florczak, A.S</creatorcontrib><creatorcontrib>Richard, M., MD</creatorcontrib><creatorcontrib>Classe, J.M., MD-PhD</creatorcontrib><creatorcontrib>Oger, A.S., MD</creatorcontrib><creatorcontrib>Raro, P., MD</creatorcontrib><creatorcontrib>Wernert, R., MD</creatorcontrib><creatorcontrib>Lorimier, G., MD</creatorcontrib><title>Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Abstract Purpose The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable invasive breast cancer. Patients and methods This retrospective single-institution study included 111 patients who underwent a mastectomy with IBR after RT and/or NACT for invasive breast carcinoma at the Institut de Cancérologie de l’Ouest Paul Papin from January 1997 to January 2012. Only patients with breast reconstruction by autologous latissimus dorsi flap with (LDI) or without (ALD) implant were considered. The primary endpoints were the delay in therapeutic sequence, post-operative complication rate, surgical revision rate, time of hospitalization and the anonymous analysis of the patient satisfaction survey. Results 111 patients underwent mastectomy after RT. The median age was 48 years old and the median body mass index (BMI) was 23.6. SSM were performed in 94.5% of cases. The median interval between the end of chemotherapy (CT) and the beginning of RT was 30 days while the median interval between the end of RT and surgery was 41 days. The rate of primary complications was 66.6% including seroma secretion (reduced to 10.8% when seroma secretion was excluded). The necrosis rate was 5.4%. The average patient satisfaction score for the reconstruction was 17 out of 20. Five-year disease-free and overall survival rates were 93.2% and 98.3% respectively with a median follow-up of 31.6 months. There was only one case of local relapse diagnosed after seven years of follow-up. Conclusion This study shows that our therapeutic sequence does not appear to increase IBR morbidity and remains within the acceptable safety margins of oncological treatment. It also gives a high quality aesthetic result that helps to maintain patient self-esteem.</description><subject>Adult</subject><subject>Aged</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Breast Neoplasms - therapy</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Carcinoma, Ductal, Breast - surgery</subject><subject>Carcinoma, Ductal, Breast - therapy</subject><subject>Chemotherapy, Adjuvant</subject><subject>Complications</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immediate breast reconstruction</subject><subject>Latissimus dorsi flap</subject><subject>Local recurrence</subject><subject>Mammaplasty - adverse effects</subject><subject>Mammaplasty - methods</subject><subject>Mastectomy - adverse effects</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy - methods</subject><subject>Neoplasm Recurrence, Local - prevention &amp; control</subject><subject>Organ Sparing Treatments</subject><subject>Patient Satisfaction</subject><subject>Prognosis</subject><subject>Radiotherapy, Adjuvant</subject><subject>Risk Factors</subject><subject>Satisfaction</subject><subject>Skin</subject><subject>Skin-sparing mastectomy</subject><subject>Superficial Back Muscles - transplantation</subject><subject>Surgery</subject><subject>Surgical Flaps</subject><subject>Time Factors</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks2O0zAUhSMEYoaBF2CBvGTTYsdO4iCEVMoAlQpI02Ft3To3U4fELrbTUd-Ux8GZzrBgwco_95zja3_OspeMzhll5Ztujl1w8zzN55TPaS4eZees4PksZ0X1ODunlZCzqpb8LHsWQkcprXlVP83O8opxwYQ8z35fHqAfIRpniWvJVwgRdXTDkdyauCOrYcDGQESyGKPr3Y0bA1kneQhmSNOPzgdDPnhMPnKF2tkQ_ajv4lrX9-7W2BvyDR003XgAG8lyh4OLO_SwPxKwDbmC6YDJcH3afUsWZJNsPZJVijNxvKtu4tgcpx4ZY2QJAcO0WNkDBHPAhx6W4LWxboDn2ZMW-oAv7seL7Meny-vll9n6--fVcrGeaVHSOGu2pW4LyFtZCC0prWRRbFshaCqISjY5h6asmWQotgwAthSlZAVUNW-qGpFfZK9PuXvvfo0YohpM0Nj3YDE9lmKSClaXVUWTND9JtXcheGzV3psB_FExqiaiqlMTUTURVZSrRDSZXt3nj9vE4q_lAWESvDsJMN3yYNCroA1anbj5hFI1zvw___0_dt0bazT0P_GIoXOjt-n9FFMhV1Rtpj81fSlWckq5LPgfDWjMbQ</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Paillocher, N., MD</creator><creator>Florczak, A.S</creator><creator>Richard, M., MD</creator><creator>Classe, J.M., MD-PhD</creator><creator>Oger, A.S., MD</creator><creator>Raro, P., MD</creator><creator>Wernert, R., MD</creator><creator>Lorimier, G., MD</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160701</creationdate><title>Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma</title><author>Paillocher, N., MD ; Florczak, A.S ; Richard, M., MD ; Classe, J.M., MD-PhD ; Oger, A.S., MD ; Raro, P., MD ; Wernert, R., MD ; Lorimier, G., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-db6cf5a2f854c8007855bf440db6478d23ad69181e4b1aaab0e8815a793d79ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Breast Neoplasms - therapy</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Carcinoma, Ductal, Breast - surgery</topic><topic>Carcinoma, Ductal, Breast - therapy</topic><topic>Chemotherapy, Adjuvant</topic><topic>Complications</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immediate breast reconstruction</topic><topic>Latissimus dorsi flap</topic><topic>Local recurrence</topic><topic>Mammaplasty - adverse effects</topic><topic>Mammaplasty - methods</topic><topic>Mastectomy - adverse effects</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy - methods</topic><topic>Neoplasm Recurrence, Local - prevention &amp; control</topic><topic>Organ Sparing Treatments</topic><topic>Patient Satisfaction</topic><topic>Prognosis</topic><topic>Radiotherapy, Adjuvant</topic><topic>Risk Factors</topic><topic>Satisfaction</topic><topic>Skin</topic><topic>Skin-sparing mastectomy</topic><topic>Superficial Back Muscles - transplantation</topic><topic>Surgery</topic><topic>Surgical Flaps</topic><topic>Time Factors</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paillocher, N., MD</creatorcontrib><creatorcontrib>Florczak, A.S</creatorcontrib><creatorcontrib>Richard, M., MD</creatorcontrib><creatorcontrib>Classe, J.M., MD-PhD</creatorcontrib><creatorcontrib>Oger, A.S., MD</creatorcontrib><creatorcontrib>Raro, P., MD</creatorcontrib><creatorcontrib>Wernert, R., MD</creatorcontrib><creatorcontrib>Lorimier, G., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paillocher, N., MD</au><au>Florczak, A.S</au><au>Richard, M., MD</au><au>Classe, J.M., MD-PhD</au><au>Oger, A.S., MD</au><au>Raro, P., MD</au><au>Wernert, R., MD</au><au>Lorimier, G., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>42</volume><issue>7</issue><spage>949</spage><epage>955</epage><pages>949-955</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Abstract Purpose The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable invasive breast cancer. Patients and methods This retrospective single-institution study included 111 patients who underwent a mastectomy with IBR after RT and/or NACT for invasive breast carcinoma at the Institut de Cancérologie de l’Ouest Paul Papin from January 1997 to January 2012. Only patients with breast reconstruction by autologous latissimus dorsi flap with (LDI) or without (ALD) implant were considered. The primary endpoints were the delay in therapeutic sequence, post-operative complication rate, surgical revision rate, time of hospitalization and the anonymous analysis of the patient satisfaction survey. Results 111 patients underwent mastectomy after RT. The median age was 48 years old and the median body mass index (BMI) was 23.6. SSM were performed in 94.5% of cases. The median interval between the end of chemotherapy (CT) and the beginning of RT was 30 days while the median interval between the end of RT and surgery was 41 days. The rate of primary complications was 66.6% including seroma secretion (reduced to 10.8% when seroma secretion was excluded). The necrosis rate was 5.4%. The average patient satisfaction score for the reconstruction was 17 out of 20. Five-year disease-free and overall survival rates were 93.2% and 98.3% respectively with a median follow-up of 31.6 months. There was only one case of local relapse diagnosed after seven years of follow-up. Conclusion This study shows that our therapeutic sequence does not appear to increase IBR morbidity and remains within the acceptable safety margins of oncological treatment. It also gives a high quality aesthetic result that helps to maintain patient self-esteem.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27134148</pmid><doi>10.1016/j.ejso.2016.03.024</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2016-07, Vol.42 (7), p.949-955
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_1804196770
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Breast Neoplasms - therapy
Carcinoma, Ductal, Breast - pathology
Carcinoma, Ductal, Breast - surgery
Carcinoma, Ductal, Breast - therapy
Chemotherapy, Adjuvant
Complications
Female
Hematology, Oncology and Palliative Medicine
Humans
Immediate breast reconstruction
Latissimus dorsi flap
Local recurrence
Mammaplasty - adverse effects
Mammaplasty - methods
Mastectomy - adverse effects
Middle Aged
Neoadjuvant Therapy - methods
Neoplasm Recurrence, Local - prevention & control
Organ Sparing Treatments
Patient Satisfaction
Prognosis
Radiotherapy, Adjuvant
Risk Factors
Satisfaction
Skin
Skin-sparing mastectomy
Superficial Back Muscles - transplantation
Surgery
Surgical Flaps
Time Factors
Transplantation, Autologous
Treatment Outcome
title Evaluation of Mastectomy with Immediate Autologous Latissimus Dorsi Breast Reconstruction following Neoadjuvant Chemotherapy and Radiation Therapy: A Single Institution Study of 111 Cases of Invasive Breast Carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T08%3A23%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Mastectomy%20with%20Immediate%20Autologous%20Latissimus%20Dorsi%20Breast%20Reconstruction%20following%20Neoadjuvant%20Chemotherapy%20and%20Radiation%20Therapy:%20A%20Single%20Institution%20Study%20of%20111%20Cases%20of%20Invasive%20Breast%20Carcinoma&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Paillocher,%20N.,%20MD&rft.date=2016-07-01&rft.volume=42&rft.issue=7&rft.spage=949&rft.epage=955&rft.pages=949-955&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2016.03.024&rft_dat=%3Cproquest_cross%3E1804196770%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1804196770&rft_id=info:pmid/27134148&rft_els_id=S0748798316300385&rfr_iscdi=true